4
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Association of human herpesvirus 6 and human herpesvirus 7 with demyelinating diseases of the nervous system

Pages 564-569 | Published online: 10 Jul 2009

References

  • Aberle SW, Mandl CW, Kunz C, Popow-Kraupp T (1996). Presence of human herpesvirus 6 variants A and B in saliva and peripheral blood mononuclear cells of healthy adults. J Clin Microbiol 34: 3223–3225.
  • Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB, Peterson DL, Pearson GR, Whitman JE (2000). Frequent HHV-6 reactivation in multiple sclero-sis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 16: 179–191.
  • Ablashi DV, Handy M, Bernbaum J, Chatlynne LG, Lapps W, Kramarsky B, Berneman ZN, Komaroff AL, Whitman JE (1998a). Propagation and characterization of hu-man herpesvirus-7 (HHV-7) isolates in a continuous T-lymphoblastoid cell line (SupTi). I Virol Methods 73: 123–140.
  • Ablashi DV, Lapps W, Kaplan M, Whitman JE, Richert JR, Pearson GR (1998b). Human herpesvirus-6 (HHV-6) in-fection in multiple sclerosis: a preliminary report. Mult Scler 4: 490–496.
  • Akhyani N, Berti R, Brennan MB, Soldan SS, Eaton JM, McFarland HF, Jacobson S (2000). Tissue distribu-tion and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. I Infect Dis 182: 1321–1325.
  • Asano Y, Suga S, Yoshikawa T, Yazaki T, Uchikawa T (1995). Clinical features and viral excretion in an infant with primary human herpesvirus 7 infection. Pediatrics 95: 187–190.
  • Asbury AK, Cornblath DR (1990). Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27 (Suppl.): S21–S24.
  • Bandobashi K, Daibata M, Kamioka M, Tanaka Y, Kubonishi I, Taguchi H, Ohtsuki Y, Miyoshi I (1997). Human her-pesvirus 6 (HHV-6)-positive Burkitt's lymphoma: estab-lishment of a novel cell line infected with HHV-6. Blood 90: 1200–1207.
  • Berneman ZN, Ablashi DV, Li G, Eger-Fletcher M, Reitz MS, Hung C-L, Brus I, Komaroff AL, Gallo RC (1992). Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci USA 89: 10552–10556.
  • Braun DK, Dominguez G, Pellett PE (1997). Human her-pesvirus 6. Clin Microbiol Rev 10: 521–567.
  • Campadelli-Fiume G, Mirandola P, Menotti L (1999). Human herpesvirus 6: an emerging pathogen. Em erg Infect Dis 5: 353–366.
  • Carrigan DR, Knox KK (1999). Pathogenic role of human herpesvirus 6 in transplantation. Curr Opin Organ Transplan 4: 285–291.
  • Caserta MT, Hall CB, Schnabel K, Long CE, D'Heron N (1998). Primary human herpesvirus 7 infection: a com-parison of human herpesvirus 7 and human herpesvirus 6 infections in children. JPediatr 133: 386–389.
  • Caserta MT, Hall CB, Schnabel K, McIntyre K, Long C, Costanzo M, Dewhurst S, Insel R, Epstein LG (1994). Neuroinvasion and persistence of human herpesvirus 6 in children. I Infect Dis 170: 1586–1589.
  • Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, Schad PA, Stewart PM, Nowinski RC, Brown JP, Burmer GC (1995). Plaque-associated expression of hu-man herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 92: 7440–7444.
  • Clark DA, Griffiths PD, Emery VC (2000). Newer human her-pesviruses in transplantation. Carr Opin Organ Trans-plan 5: 203–209.
  • Frenkel N, Schirmer EC, Wyatt LS, Katsafanas G, Roffman E, Danovich RM, June CH (1990). Isolation of a new her-pesvirus from human CD4+ T cells. Proc Natl Acad Sci USA 87: 748–752.
  • Hall CB, Long CE, Schnabel KC, Caserta MT, McIntyre KM, Costanzo MA, Knott A, Dewhurst S, Insel RA, Epstein LG (1994). Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 331: 432–438.
  • Hay KA, Tenser RB (2000). Leukotropic herpesviruses in multiple sclerosis. Mult Scler 6: 66–68.
  • He J, McCarthy M, Zhou Y, Chandran B, Wood C (1996). Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 70: 1296–1300.
  • Katsafanas GC, Schirme EC, Wyatt LS, Frenkel N (1996). In vitro activation of human herpesviruses 6 and 7 from latency. Proc Natl Acad Sci USA 93: 9788–9792.
  • Knox KK, Brewer JH, Henry JM, Harrington DJ, Carrigan DR (2000). Human herpesvirus 6 and multiple sclerosis: systemic active infection in patients with early disease. Clin Infect Dis 31: 894–903.
  • Nicholas J (1996). Determination and analysis of the com-plete nucleotide sequence of human herpesvirus 7. I Virol 70: 5975–5989.
  • Pfeiffer B, Thomson B, Chandran B (1995). Identification and characterization of a cDNA derived from multiple splicing that encodes envelope glycoprotein gp105 of human herpesvirus 6. J Virol 69: 3490–3500.
  • Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983). New diagnostic criteria for mul-tiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227–231.
  • Rojo J, Bonifaz R, Koch B, Krueger GR (1995). Initial studies of the prevalence of human herpesvirus 7 (HHV-7) in Mexican blood donors. Patho/ogie 16: 204–207.
  • Rotola A, Caselli E, Cassai E, Tola MR, GranieriE, Luca DD (2000). Novel human herpesviruses and multiple scle-rosis. J NeuroVirol 6 (Suppl 2): S88–S91.
  • Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, Gallo RC (1986). Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234: 596–601.
  • Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL, Gallo RC, Lusso P (1995). Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. /Infect Dis 171: 273–280.
  • Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Moloni HW, McFarland HF, Lin HC, Patriaik M, Jacobson S (1997). Association of human herpes virus 6 (HHV-6) with multiple sclero-sis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 3: 1394–1397.
  • Tanaka K, Kondo T, Torigoe S, Okada S, Mukai T, Yamanishi K (1994). Human herpesvirus 7: another causal agent for rose ola (exanthem subitum). J Pediatr 125: 1–5.
  • Tanaka-Taya K, Kondo T, Nakagawa N, Inagi R, Miyoshi H, Sunagawa T, Okada S, Yamanishi K (2000). Reacti-vation of human herpesvirus 6 by infection of human herpesvirus 7. J. Med Virol 60: 284–289.
  • Taus C, Pucci E, Cartechini E, Fie A, Giuliani G, Clementi M, Menzo S (2000). Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple scle-rosis. Acta Neurol Scand 101: 224–228.
  • Thawaranantha D, Chimabutra K, Balachandra K, Warachi P, Pantuwatana S, Inagi R, Kurata T, Yamanishi K (1999). Prevalences of human herpesvirus 6 and human her-pesvirus 7 in normal Thai population. Southeast Asian I Trop Med Public Health 30: 259–264.
  • Torigoe S, Koide W, Yamada M, Miyashiro E, Tanaka-Taya K, Yamanishi K (1996). Human herpesvirus 7 infection associated with central nervous system manifestations. J Pediatr 129: 301–305.
  • Van den Berg JSP, van Zeijl JH, Rotteveel JJ, Melchers JS, Gabreels FJM, Galama JMD (1999). Neuroinvasion by human herpesvirus type 7 in a case of exanthem subi-tum with severe neurologic manifestations. Neurology 52: 1077–1079.
  • Vandamme A-M, Fransen K, Debaisieux I, Marissens D, Sprecher S, Vaira D, Vanderbroucke AT, Verhofstede C (1995). Standardization of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbour-ing strains of diverse geographical origin. The Belgian AIDS Reference Laboratories. I Virol Methods 51: 305–316.
  • Wilborn F, Schmidt CA, Lorenz F, Peng R, Gelderblom H, Huhn D, Siegert W (1995). Human herpesvirus type 7 in blood donors: detection by the polymerase chain reac-tion. J Med Virol 47: 65–69.
  • Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T (1988). Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1: 1065–1067.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.